| 11572 | Humans |
| 7992 | Lymphedema |
| 6625 | Female |
| 4496 | Male |
| 4165 | Middle Aged |
| 4103 | Adult |
| 2787 | Aged |
| 2542 | Animals |
| 2283 | Elephantiasis, Filarial |
| 1872 | Breast Neoplasms |
| 1559 | Adolescent |
| 1301 | Leg |
| 1178 | Child |
| 1055 | Wuchereria bancrofti |
| 1005 | Arm |
| 942 | Lymphatic System |
| 940 | Lymph Node Excision |
| 913 | Postoperative Complications |
| 869 | Aged, 80 and over |
| 853 | Elephantiasis |
| 852 | Treatment Outcome |
| 820 | Mastectomy |
| 752 | Lymphography |
| 699 | Lymph Nodes |
| 682 | Child, Preschool |
| 666 | Follow-Up Studies |
| 616 | Diagnosis, Differential |
| 569 | Edema |
| 555 | Chronic Disease |
| 542 | Lymphatic Metastasis |
| 514 | Filariasis |
| 507 | Retrospective Studies |
| 506 | Time Factors |
| 496 | Lymphatic Vessels |
| 489 | Risk Factors |
| 489 | Infant |
| 484 | Young Adult |
| 454 | Quality of Life |
| 454 | Axilla |
| 436 | Prevalence |
| 428 | Antigens, Helminth |
| 408 | Skin Neoplasms |
| 406 | Filaricides |
| 403 | Diethylcarbamazine |
| 401 | Syndrome |
| 394 | Microfilariae |
| 365 | Combined Modality Therapy |
| 352 | Lower Extremity |
| 349 | Brugia |
| 343 | Physical Therapy Modalities |
| 342 | Prospective Studies |
| 336 | Prognosis |
| 334 | India |
| 330 | Surveys and Questionnaires |
| 328 | Skin |
| 322 | Neoplasm Staging |
| 319 | Drainage |
| 308 | Bandages |
| 307 | Neoplasms |
| 301 | Mice |
| 285 | Microsurgery |
| 281 | Sentinel Lymph Node Biopsy |
| 279 | Infant, Newborn |
| 265 | Radionuclide Imaging |
| 264 | Veins |
| 251 | Lymphatic Diseases |
| 251 | Antibodies, Helminth |
| 250 | Scrotum |
| 241 | Brugia malayi |
| 236 | Insect Vectors |
| 236 | Extremities |
| 235 | Lymphangiosarcoma |
| 233 | Lymphoscintigraphy |
| 225 | Lymph |
| 219 | Venous Insufficiency |
| 217 | Cross-Sectional Studies |
| 216 | Hemangiosarcoma |
| 210 | Severity of Illness Index |
| 210 | Anastomosis, Surgical |
| 208 | Disease Models, Animal |
| 206 | Magnetic Resonance Imaging |
| 201 | Neoplasm Recurrence, Local |
| 200 | Methods |
| 199 | Radiotherapy |
| 199 | Incidence |
| 197 | Upper Extremity |
| 197 | Endemic Diseases |
| 196 | Surgical Flaps |
| 195 | Ivermectin |
| 191 | Lymphangiogenesis |
| 189 | Pressure |
| 188 | Tomography, X-Ray Computed |
| 187 | Enzyme-Linked Immunosorbent Assay |
| 182 | Exercise Therapy |
| 179 | Dogs |
| 178 | Sensitivity and Specificity |
| 178 | Immunoglobulin G |
| 178 | Age Factors |
| 174 | Survivors |
| 174 | Genital Diseases, Male |
| 174 | Biopsy |
| 170 | Recurrence |
| 169 | Albendazole |
| 168 | Massage |
| 157 | Skin Transplantation |
| 155 | Varicose Veins |
| 155 | Culex |
| 155 | Carcinoma, Squamous Cell |
| 154 | Thrombophlebitis |
| 154 | Melanoma |
| 154 | Lymphangitis |
| 153 | Ultrasonography |
| 152 | Radiotherapy, Adjuvant |
| 151 | Radiography |
| 150 | Skin Diseases |
| 150 | Reproducibility of Results |
| 149 | Rats |
| 144 | Uterine Cervical Neoplasms |
| 141 | Pleural Effusion |
| 139 | Patient Education as Topic |
| 137 | Anthelmintics |
| 136 | Obesity |
| 134 | Vascular Diseases |
| 134 | Disease |
| 134 | Case-Control Studies |
| 132 | Drug Therapy, Combination |
| 131 | Pregnancy |
| 130 | Pedigree |
| 129 | Cellulitis |
| 127 | Penile Diseases |
| 126 | Phlebography |
| 125 | Erysipelas |
| 120 | Nail Diseases |
| 119 | Onchocerciasis |
| 118 | Wound Healing |
| 118 | Anti-Bacterial Agents |
| 117 | Stockings, Compression |
| 117 | Phenotype |
| 117 | Cohort Studies |
| 116 | Penis |
| 116 | Pain |
| 114 | Testicular Hydrocele |
| 112 | Vascular Endothelial Growth Factor Receptor-3 |
| 112 | Risk Assessment |
| 112 | Reconstructive Surgical Procedures |
| 112 | Mutation |
| 112 | Leg Ulcer |
| 110 | Vulvar Neoplasms |
| 110 | Mastectomy, Segmental |
| 108 | Transplantation, Autologous |
| 108 | Postoperative Care |
| 108 | Pilot Projects |
| 106 | Lymphangioma |
| 105 | Predictive Value of Tests |
| 103 | Mastectomy, Radical |
| 103 | Immunohistochemistry |
| 101 | Compression Bandages |
| 100 | Sex Factors |
| 100 | Self Care |
| 100 | Lymphangiectasis |
| 100 | Abnormalities, Multiple |
| 99 | Health Knowledge, Attitudes, Practice |
| 98 | Vascular Endothelial Growth Factor C |
| 98 | Survival Rate |
| 98 | Groin |
| 96 | Mosquito Control |
| 96 | Gerbillinae |
| 95 | Drug Administration Schedule |
| 94 | Larva |
| 93 | Radiation Injuries |
| 93 | Ethiopia |
| 91 | Neoplasm Metastasis |
| 91 | Culicidae |
| 91 | Contrast Media |
| 91 | Adenocarcinoma |
| 90 | Range of Motion, Articular |
| 90 | Molecular Sequence Data |
| 90 | Hand |
| 90 | Chyle |
| 90 | Age Distribution |
| 89 | Lipectomy |
| 89 | Genital Neoplasms, Female |
| 89 | Endothelial Cells |
| 87 | Hysterectomy |
| 87 | Adipose Tissue |
| 86 | Soft Tissue Neoplasms |
| 86 | Rural Population |
| 85 | Randomized Controlled Trials as Topic |
| 85 | Inflammation |
| 85 | Global Health |
| 85 | Carcinoma |
| 85 | Breast |
| 85 | Acute Disease |
| 84 | Inguinal Canal |
| 83 | Double-Blind Method |
| 83 | Chylothorax |
| 82 | Lymphangiectasis, Intestinal |
| 82 | Coumarins |
| 81 | Sarcoma, Kaposi |
| 81 | Palliative Care |
| 81 | Longitudinal Studies |
| 81 | Hindlimb |
| 80 | Patient Compliance |
| 79 | Turner Syndrome |
| 79 | Skin Care |
| 79 | Malaria |
| 79 | Body Mass Index |
| 79 | Antineoplastic Combined Chemotherapy Protocols |
| 78 | Pigmentation Disorders |
| 78 | Obesity, Morbid |
| 78 | Exercise |
| 78 | Anopheles |
| 77 | Wuchereria |
| 77 | Polymerase Chain Reaction |
| 77 | Forkhead Transcription Factors |
| 77 | Cells, Cultured |
| 76 | Electric Impedance |
| 76 | Disease Progression |
| 75 | Indocyanine Green |
| 75 | Chemotherapy, Adjuvant |
| 75 | Anthropometry |
| 74 | United Kingdom |
| 74 | Radiopharmaceuticals |
| 74 | Coloring Agents |
| 74 | Activities of Daily Living |
| 72 | Vascular Surgical Procedures |
| 72 | Leg Dermatoses |
| 72 | Feasibility Studies |
| 72 | Cytokines |
| 72 | Antineoplastic Agents |
| 72 | Adaptation, Psychological |
| 71 | United States |
| 71 | Survival Analysis |
| 71 | Socioeconomic Factors |
| 71 | Rural Health |
| 71 | Models, Biological |
| 71 | Fatal Outcome |
| 71 | Brazil |
| 70 | Varicose Ulcer |
| 70 | Amputation |
| 69 | Recombinant Proteins |
| 69 | Population Surveillance |
| 69 | Mice, Inbred C57BL |
| 69 | Fibrosis |
| 69 | Eyelashes |
| 68 | Technetium |
| 68 | Head and Neck Neoplasms |
| 68 | China |
| 67 | Thigh |
| 67 | Surgical Wound Infection |
| 67 | Rabbits |
| 66 | Radiotherapy Dosage |
| 66 | Nursing Assessment |
| 66 | Lymphoma |
| 66 | Disease-Free Survival |
| 66 | Analysis of Variance |
| 66 | Amino Acid Sequence |
| 65 | Neglected Diseases |
| 65 | Lymphocyte Activation |
| 65 | Carcinoma, Ductal, Breast |
| 64 | Tanzania |
| 64 | Signal Transduction |
| 64 | Saphenous Vein |
| 64 | Clothing |
| 64 | Antibodies, Monoclonal |
| 62 | Mammaplasty |
| 62 | Equipment Design |
| 62 | Endometrial Neoplasms |
| 61 | Soil |
| 61 | Pelvis |
| 61 | Mice, Inbred BALB C |
| 61 | Logistic Models |
| 61 | Haiti |
| 60 | Schistosomiasis |
| 60 | Medical Records |
| 59 | Morbidity |
| 59 | Microscopy, Electron |
| 59 | Lymphadenitis |
| 59 | Carrier State |
| 59 | Base Sequence |
| 59 | Aedes |
| 58 | Preoperative Care |
| 58 | Practice Guidelines as Topic |
| 58 | Foot |
| 57 | Tropical Medicine |
| 57 | Angiography |
| 56 | World Health Organization |
| 56 | Surgical Procedures, Operative |
| 56 | Sex Distribution |
| 56 | Genetic Predisposition to Disease |
| 56 | Foot Diseases |
| 56 | Attitude to Health |
| 55 | Filarioidea |
| 54 | Program Evaluation |
| 54 | Patient Care Team |
| 54 | Forearm |
| 54 | Diuretics |
| 54 | Disease Eradication |
| 54 | Comorbidity |
| 53 | Proteins |
| 53 | Penile Neoplasms |
| 53 | Neoplasm Invasiveness |
| 53 | Mastectomy, Modified Radical |
| 53 | Helminth Proteins |
| 52 | Thoracic Duct |
| 52 | Regional Blood Flow |
| 52 | Myxedema |
| 52 | Multivariate Analysis |
| 52 | Macrophages |
| 52 | Face |
| 51 | Vulva |
| 51 | Prostatic Neoplasms |
| 51 | Phlebitis |
| 51 | Helminthiasis |
| 51 | Evidence-Based Medicine |
| 51 | Developing Countries |
| 51 | Chylous Ascites |
| 50 | Vulvar Diseases |
| 50 | Venous Thrombosis |
| 50 | Technetium Tc 99m Aggregated Albumin |
| 50 | Neck |
| 50 | Clinical Trials as Topic |
| 50 | Biomarkers |
| 49 | Thrombosis |
| 49 | T-Lymphocytes |
| 49 | Shoulder |
| 49 | Leg Injuries |
| 49 | Fatigue |
| 49 | Capillary Permeability |
| 48 | Social Support |
| 48 | Hyperplasia |
| 48 | Cell Proliferation |
| 48 | Capillaries |
| 48 | Arthritis, Rheumatoid |
| 47 | Wolbachia |
| 47 | Necrosis |
| 47 | Immunity, Cellular |
| 47 | Health Surveys |
| 47 | Africa |
| 46 | Surgery, Plastic |
| 46 | Regression Analysis |
| 46 | Regeneration |
| 46 | Papua New Guinea |
| 46 | Omentum |
| 46 | Hodgkin Disease |
| 46 | History, 20th Century |
| 45 | Tumor Suppressor Proteins |
| 45 | Technetium Tc 99m Sulfur Colloid |
| 45 | Parasitemia |
| 45 | Nigeria |
| 45 | Neoplasms, Radiation-Induced |
| 45 | Intermittent Pneumatic Compression Devices |
| 45 | Genotype |
| 45 | Endothelium, Lymphatic |
| 45 | Cats |
| 44 | Protein-Losing Enteropathies |
| 44 | Neoplasms, Second Primary |
| 44 | Lymphocytes |
| 44 | Immunoglobulin E |
| 44 | Femoral Vein |
| 44 | DNA, Helminth |
| 44 | Biopsy, Needle |
| 44 | Algorithms |
| 43 | Sarcoma |
| 43 | Reoperation |
| 43 | Postoperative Period |
| 43 | Liver |
| 43 | Indonesia |
| 43 | Ghana |
| 42 | Transcription Factors |
| 42 | Physical Examination |
| 42 | Granuloma |
| 42 | Genitalia |
| 42 | Dose-Response Relationship, Drug |
| 42 | Depression |
| 42 | Communicable Disease Control |
| 42 | Body Image |
| 41 | Public Health |
| 41 | Posture |
| 41 | Pain Measurement |
| 41 | Noonan Syndrome |
| 41 | Microcirculation |
| 41 | Mice, Knockout |
| 41 | Cost of Illness |
| 41 | Blood Vessels |
| 40 | Toes |
| 40 | Patient Satisfaction |
| 40 | Neurofibromatosis 1 |
| 40 | Nails |
| 40 | Lymphocele |
| 40 | Hemangioma |
| 40 | Heart Failure |
| 40 | Extracellular Space |
| 40 | Diagnostic Imaging |
| 40 | Cicatrix |
| 40 | Abdomen |
| 39 | Uterine Neoplasms |
| 39 | Risk |
| 39 | Reference Values |
| 39 | Qualitative Research |
| 39 | Plethysmography |
| 39 | Microcephaly |
| 39 | Health Status |
| 39 | Eyelid Diseases |
| 39 | Evaluation Studies as Topic |
| 39 | Disease Vectors |
| 39 | Antiparasitic Agents |
| 38 | Length of Stay |
| 38 | Egypt |
| 38 | Blood Pressure |
| 37 | Yellow Nail Syndrome |
| 37 | Wounds and Injuries |
| 37 | Streptococcal Infections |
| 37 | Shoulder Joint |
| 37 | Recovery of Function |
| 37 | Organ Size |
| 37 | Neovascularization, Pathologic |
| 37 | Mice, Transgenic |
| 37 | Karyotyping |
| 37 | Iliac Vein |
| 37 | Blotting, Western |
| 37 | Blood Proteins |
| 37 | Arterial Occlusive Diseases |
| 37 | Administration, Oral |
| 36 | Vascular Endothelial Growth Factor A |
| 36 | Lung Neoplasms |
| 36 | Ligation |
| 36 | Interferon-gamma |
| 36 | Intellectual Disability |
| 36 | Genitalia, Male |
| 36 | Fluorescent Antibody Technique |
| 36 | Fistula |
| 36 | Disease Management |
| 36 | Cost-Benefit Analysis |
| 36 | Connective Tissue |
| 36 | Cloning, Molecular |
| 36 | Breast Diseases |
| 36 | Anticoagulants |
| 35 | Venous Pressure |
| 35 | Suture Techniques |
| 35 | Stress, Psychological |
| 35 | Sri Lanka |
| 35 | Research |
| 35 | Pelvic Neoplasms |
| 35 | Klippel-Trenaunay-Weber Syndrome |
| 35 | Insecticides |
| 35 | Immunosuppressive Agents |
| 35 | Homeodomain Proteins |
| 35 | Drug Combinations |
| 35 | DNA Mutational Analysis |
| 35 | Burns |
| 35 | Anti-Inflammatory Agents |
| 34 | Patient Selection |
| 34 | Pain, Postoperative |
| 34 | Pain Management |
| 34 | Neoplasms, Multiple Primary |
| 34 | Kenya |
| 34 | Gene Expression Regulation |
| 34 | Collagen |
| 34 | Breast Cancer Lymphedema |
| 33 | Lung Diseases |
| 33 | Ischemia |
| 33 | Host-Parasite Interactions |
| 33 | Genes, Dominant |
| 33 | DNA-Binding Proteins |
| 33 | Anxiety |
| 32 | Thailand |
| 32 | Statistics, Nonparametric |
| 32 | Skin Ulcer |
| 32 | Referral and Consultation |
| 32 | Neovascularization, Physiologic |
| 32 | Interviews as Topic |
| 32 | Health Education |
| 32 | Epitopes |
| 32 | Doxycycline |
| 32 | Cell Movement |
| 32 | Body Composition |
| 31 | Polynesia |
| 31 | Lung |
| 31 | Laparoscopy |
| 31 | International Cooperation |
| 31 | History, 19th Century |
| 31 | Health Services Needs and Demand |
| 31 | Focus Groups |
| 31 | Fluorescent Dyes |
| 31 | Fever |
| 31 | Crohn Disease |
| 31 | Blood |
| 31 | Australia |
| 31 | Acquired Immunodeficiency Syndrome |
| 30 | Urine |
| 30 | Urban Population |
| 30 | Tropical Climate |
| 30 | Preventive Health Services |
| 30 | Ovarian Neoplasms |
| 30 | Kidney Transplantation |
| 30 | Immunoglobulin M |
| 30 | Fingers |
| 30 | Eosinophilia |
| 30 | Electrophoresis, Polyacrylamide Gel |
